Delivery Order SPE2DR25D3016-SPE2DR26FG2ES
- Not listed
- The Defense Logistics Agency awarded a $1,008.00 delivery order to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml suspension (60 ml) on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price contract, with no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,801.29 to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml suspension in 60ml quantities. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of October 24, 2025. The award was issued on October 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication...
- The Defense Logistics Agency awarded a $2,368.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,408.32 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This contract, executed on December 11, 2025, with completion scheduled for December 12, 2025, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. The delivery location is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml suspension (60ml) with a contract value of $3,047.20 on December 3, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by December 4, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $13,005.54 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 75mg (10-count units) on November 7, 2025, with completion scheduled for December 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count packages) with a ceiling value of $1,890.00. This firm fixed-price delivery order is set to be completed by December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award with no set-aside designation, issued under...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging. This contract, valued at $2,497.20 with a firm fixed price structure, represents a small delivery order with an ultimate completion date of December 16, 2025. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a $7,491.60 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10. This is a firm fixed-price contract with performance completion targeted for December 9, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2ESDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities, with a contract ceiling value of $1,450.25. This firm fixed-price delivery order, which has no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 16, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999.9 million and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems, including the Defense Health Agency and U.S. Coast Guard. Oseltamivir, an antiviral medication commonly used for influenza treatment and prophylaxis, reflects the type of critical pharmaceutical inventory maintained through this prime vendor arrangement to support defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/14/25 |